Molecular mechanisms underlying group A streptococcal pathogenesis

Cellular Microbiology
Randall J OlsenJames M Musser

Abstract

Group A Streptococcus (GAS) is a versatile human pathogen causing diseases ranging from uncomplicated mucosal infections to life-threatening invasive disease. The development of human-relevant animal models of GAS infection and introduction of new technologies have markedly accelerated the pace of discoveries related to GAS host-pathogen interactions. For example, recently investigators have identified pili on the GAS cell surface and learned that they are key components for adherence to eukaryotic cell surfaces. Similarly, the recent development of a transgenic mouse expressing human plasminogen has resulted in new understanding of the molecular processes contributing to invasive infection. Improved understanding of the molecular mechanisms underlying the pathogenesis of GAS pharyngeal, invasive and other infections holds the promise of assisting with the development of novel preventive or therapeutic agents for this prevalent human pathogen.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E Hanski, M Caparon
Aug 5, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F B TaylorD L Stevens
Feb 9, 2000·Trends in Biochemical Sciences·M A ParryI Bode
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Feb 13, 2001·Infection and Immunity·M S ChausseeJ M Musser
Apr 9, 2002·Oral Diseases·A V Nieuw Amerongen, E C I Veerman
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Nancy P HoeJames M Musser
Jul 11, 2002·Annals of Medicine·Harry S CourtneyJames B Dale
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Stephen B BeresJames M Musser
Sep 11, 2002·European Journal of Immunology·Anna Norrby-TeglundMalak Kotb
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Morag R GrahamJames M Musser
Mar 21, 2003·Biochemical and Biophysical Research Communications·Robyn Woodbury, W G Haldenwang
Apr 8, 2003·The Lancet Infectious Diseases·A L BisnoC M Collins
Sep 23, 2003·Infection and Immunity·Sai Sudha PurushothamanP Patrick Cleary
Nov 19, 2003·Scandinavian Journal of Infectious Diseases·M KotbD E Low
Feb 21, 2004·The Journal of Infectious Diseases·Per AkessonBertil Christensson
Aug 3, 2004·Nature Genetics·A John IafrateCharles Lee
Jan 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Paul SumbyJames M Musser
Jun 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kimmo VirtanevaJames M Musser
Jul 19, 2005·Emerging Infectious Diseases·Stephanie H FactorAnne Schuchat
Oct 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Marirosa MoraJohn L Telford
Oct 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin Llewelyn
Oct 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Samuel A ShelburneJames M Musser
Oct 29, 2005·The Lancet Infectious Diseases·Jonathan R CarapetisMartin Weber
Nov 30, 2005·The American Journal of Pathology·James M Musser, Frank R DeLeo
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·C Kent BrownCathleen A Earhart
Jan 13, 2006·PLoS Medicine·Pontus ThulinAnna Norrby-Teglund
Feb 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Beinan WangPatrick P Cleary

❮ Previous
Next ❯

Citations

Sep 26, 2013·Applied Microbiology and Biotechnology·Jacelyn M S Loh, Thomas Proft
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Randall J OlsenJames M Musser
Feb 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hongmin SunDavid Ginsburg
Jan 21, 2012·The Journal of Biological Chemistry·Shivani AgarwalVijay Pancholi
Apr 25, 2013·The Journal of Antimicrobial Chemotherapy·Emily L PowellJanet A Wilson
Sep 2, 2009·Microbiology and Molecular Biology Reviews : MMBR·Angela H NobbsHoward F Jenkinson
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Martina L Sanderson-SmithJason D McArthur
Sep 5, 2009·The Journal of Clinical Investigation·James M Musser, Samuel A Shelburne
Dec 8, 2010·Future Microbiology·Tomas FiedlerBernd Kreikemeyer
Apr 1, 2010·Future Microbiology·Debra E Bessen, Sergio Lizano
Apr 4, 2012·Emerging Infectious Diseases·Nahuel FittipaldiJames M Musser
Oct 26, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-N LinY-H Chen
Sep 10, 2009·Annual Review of Pathology·Randall J Olsen, James M Musser
Feb 14, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E GolińskaM Strus
Dec 26, 2015·Pathogens and Disease·Márcia DinisAgnès Fouet
Jun 18, 2016·FEBS Letters·Stephan BrouwerMark J Walker
Aug 23, 2016·Biochemical and Biophysical Research Communications·Bonsu KuSeung Jun Kim
Sep 12, 2015·The International Journal of Lower Extremity Wounds·Sadanori Akita
Jun 13, 2017·Metallomics : Integrated Biometal Science·Hualiang Pi, John D Helmann
Jul 14, 2018·The Journal of Biological Chemistry·Inga-Maria FrickLars Björck
May 20, 2015·Infection and Immunity·Ramona NitzscheSonja Oehmcke-Hecht
Apr 4, 2014·Clinical Microbiology Reviews·Mark J WalkerVictor Nizet
Feb 11, 2014·Current Protocols in Microbiology·Kanika Gera, Kevin S McIver

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.